BALAAM STREET PRACTICE — All Prescriptions & Medications — Page 8
Practice Code: F84681 | LONDON, E13 8AF
Showing results 351-400 of 546
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Powder extensively hydrolysed formula (0913101) | 32 | 53.2K | £1.5K | -55.6% ▼ |
| Metoclopramide hydrochloride | 31 | 1,755 | £66 | -62.6% ▼ |
| Medroxyprogesterone acetate | 31 | 31 | £180 | -74.3% ▼ |
| 31 | 1,182 | £1.3K | -69.7% ▼ | |
| 31 | 1,570 | £561 | -61.5% ▼ | |
| Bezafibrate | 30 | 960 | £128 | -44.3% ▼ |
| Glucose | 30 | 6,475 | £572 | -42.3% ▼ |
| 30 | 330 | £41 | -20.2% ▼ | |
| Levocetirizine | 29 | 870 | £114 | +86.1% ▲ |
| Co-beneldopa (Benserazide/levodopa) | 29 | 2,900 | £245 | -80.8% ▼ |
| Fusidic acid | 29 | 145 | £547 | +180.7% ▲ |
| Chlorhexidine gluconate | 29 | 12.9K | £121 | +32.1% ▲ |
| Pimecrolimus | 29 | 1,240 | £749 | +71.3% ▲ |
| 29 | 7,850 | £1.1K | -25.5% ▼ | |
| Glycopyrronium bromide | 28 | 9,930 | £5.1K | +36.4% ▲ |
| Zinc oxide | 28 | 793 | £96 | +35.3% ▲ |
| Omega-3-acid ethyl esters | 28 | 1,904 | £920 | +32.5% ▲ |
| Methylphenidate hydrochloride | 28 | 1,524 | £1.1K | -89.2% ▼ |
| Terbinafine hydrochloride | 28 | 1,140 | £550 | -54.7% ▼ |
| Exemestane | 28 | 840 | £153 | -13.8% ▼ |
| Tamoxifen citrate | 28 | 840 | £72 | -66.0% ▼ |
| Ready to serve infant formula, high energy (0913104) | 28 | 306.9K | £4.5K | +153.4% ▲ |
| Calamine | 28 | 5,100 | £43 | +269.4% ▲ |
| 28 | 2,020 | £600 | -4.7% ▼ | |
| Sotalol hydrochloride | 27 | 2,688 | £74 | -61.6% ▼ |
| Hyoscine | 27 | 810 | £5.2K | +289.0% ▲ |
| Dutasteride | 27 | 786 | £45 | -47.4% ▼ |
| Letrozole | 27 | 756 | £73 | -85.5% ▼ |
| Other compound vitamin/mineral formulation preparations | 27 | 1,620 | £205 | -15.8% ▼ |
| Acetazolamide | 27 | 1,932 | £74 | +24.6% ▲ |
| 27 | 766 | £241 | -19.1% ▼ | |
| Powder preterm infant formula (0913111) | 26 | 61.6K | £994 | +63.3% ▲ |
| Lidocaine hydrochloride | 26 | 750 | £704 | -84.9% ▼ |
| Losartan potassium with diuretic | 25 | 980 | £126 | -2.5% ▼ |
| Febuxostat | 25 | 812 | £62 | -33.1% ▼ |
| Metronidazole | 25 | 1,235 | £343 | -33.5% ▼ |
| Telmisartan | 24 | 672 | £124 | -58.6% ▼ |
| Domperidone | 24 | 7,097 | £1.6K | -32.7% ▼ |
| Fentanyl | 24 | 355 | £1.6K | -76.6% ▼ |
| Tapentadol | 24 | 1,582 | £704 | -41.7% ▼ |
| Testosterone | 24 | 2,049 | £679 | -68.5% ▼ |
| Apraclonidine | 24 | 120 | £248 | +90.5% ▲ |
| 24 | 72 | £352 | -22.6% ▼ | |
| 24 | 24 | £110 | -53.2% ▼ | |
| 24 | 500 | £2.4K | -46.9% ▼ | |
| Hydralazine hydrochloride | 23 | 1,288 | £66 | -45.5% ▼ |
| Co-careldopa (Carbidopa/levodopa) | 23 | 2,334 | £185 | -89.8% ▼ |
| Ready to serve 1.5 kcal/ml milkshake (0913021) | 23 | 406.0K | £9.9K | +115.6% ▲ |
| Clindamycin/tretinoin | 23 | 690 | £261 | +95.9% ▲ |
| Topiramate | 22 | 1,240 | £494 | -87.6% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.